🟢 Tiziana Life Sciences is trading 12.83% up in pre-market; no confirmed catalyst identified

Tiziana Life Sciences is trading at $0.70, up 12.83% in pre-market, with no confirmed catalyst for the November 6 rise. - On November 5, the company announced a November 9 investor call about positive Phase 2a INFORM-MS results; coverage does not establish that it caused the move. - Results showed a significant imaging finding at 50 μg and fatigue improvements in both dose groups; 100 μg had no significant PET difference. - Mixed broad-market indicators do not establish a market-wide explanation.